MSVDX Mutual Fund (Vitality Portfolio Class I) is managed by Morgan Stanley Investment Management. MSVDX expense ratio is 0.95%, holding 33 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2021-12-31.

MSVDX performance shows a YTD return of 1.22%. The 1-year return is 29.47%. MSVDX dividend yield stands at 1.50%, paid annually.

MSVDX top holdings include Argenx Se Spon Adr Each Rep 1 Ord Shs (8.0%), Eli Lilly & Co (7.8%), Ascendis Pharma As Adr (5.5%), Nektar Therapeutics Class A (4.8%), Thermo Fisher (4.3%). View all MSVDX holdings, sector breakdown, or dividend history.

MSVDX can be compared against other funds using the overlap calculator or side-by-side comparison tool. MSVDX alternatives are available via the screener, along with tax-loss harvesting opportunities.